A Population Pharmacokinetic Approach to Understand the Effect of Efavirenz on CYP3A Activity in Healthy Volunteers Using Midazolam as a Probe.

However, the latter did not reach statistical significance, likely due to the small number of intermediate metabolizers enrolled in the study ( n = 4) and the smaller effect size of the CYP3A4 genotype on drug clearance.

also in 111,027 other papers